THE GLOBAL GENOME SEQUENCING MARKET SIZE WAS VALUED AT USD 2.9 BILLION IN 2020 AND IS EXPECTED TO REACH 5 BILLION BY 2026, GROWING AT A CAGR OF 9% DURING THE FORECAST PERIOD

Genome Sequencing Market Size, Share, Trends Analysis Report by Products (Consumables and Sequencers & Software); Application (Oncology, Reproductive Health, Complex Disease Research, Microbial Research, and Others); End-user (Academic & Research Institutes, Pharma & Biotech Companies, Consumer Genomic Service Providers, Government & Commercial Laboratories, and Others); Geography (North America, Europe, APAC, Latin America, and Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

266 Pages

68 Tables

139 Charts

5 Regions

19 Countries

21 Companies

4 Market Segment

GLOBAL GENOME SEQUENCING MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) 5 BILLION (2026)
CAGR 9% (2021–2026)
Base Year 2020
Forecast Year 2021–2026
Market Segments Products (Consumables and Sequencers & Software); Application (Oncology, Reproductive Health, Complex Disease Research, Microbial Research, and Others); End-user (Academic & Research Institutes, Pharma & Biotech Companies, Consumer Genomic Service Providers, Government & Commercial Laboratories, and Others)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Saudi Arabia, Turkey, South Africa, and UAE

INDUSTRY INSIGHTS

The global genome sequencing market size was valued at USD 2.9 billion in 2020 and is expected to reach USD 5 billion by 2026, growing at a CAGR of 9% during 2021-2026.

The constant increase in cancer cases is proportionately increasing the number of sequencing-based diagnostics and treatment options in the market. With pharma and biotechnological companies displaying a keen interest in genome sequencing, vendors provide an innovative portfolio of next-generation sequencing(NGS) systems, products, and services. Drug companies have launched medicines targeting DNA and RNA, which is expected to influence the global genome sequencing market significantly. Factors such as increasing awareness and strong interests from the individuals to know about their genomics are boosting the demand.

GLOBAL GENOME SEQUENCING MARKET: KEY HIGHLIGHTS

  • Consumables are expected to witness an incremental growth of over USD 2 billion by 2026.
  • The application of oncology genome sequencing is expected to grow at a CAGR of approx. 10% during 2020–2026.
  • The revenue contribution from academic and research institutes is likely to cross over USD 16 billion by 2026
  • Consumer genomic service providers are projected to grow at the highest CAGR of approx. 10% during 2020–2026
  • North America and Europe are likely to account for the highest genome sequencing market share during the forecast period

Key Opportunities in The Market:

  • Increase in the demand for single-cell sequencing
  • Introduction Of Portable Devices
  • Emergence Of Nanopore, Third Generation Genome Sequencing Platform

MARKET SHARE & SEGMENTS

High innovations and the introduction of high throughput technologies are likely to drive the application of DNA sequencing devices.

The steady rise in the sale of high-end consumables in commercial laboratories, research institutes, academic institutes, and large pharma and biotech companies performing a high volume of sequencing-based processes is a significant factor responsible growth of consumables segment. In 2020, the consumables segment accounted for the largest share in the market, with 81%. The recurring application of consumables to perform a wide range of studies and diagnostics is another critical factor for high sales for consumables. Moreover, increased preference for array-based genotyping consumables for a wide range of analysis, disease-related mutations, and genetic characteristics associated with cancer research is further expected to increase the demand for consumables during the forecast period.

NGS changing the future of oncology

New cancer cases are expected to reach 24 million by 2030, which is likely to augur well for the growth of the oncology segment. As cancer prevalence is growing, the need for effective patient stratification is driving research efforts to identify biomarkers and develop companion diagnostics. DNA sequencing technology has opened new ways of studying cancer-related conditions. With targeted therapies becoming the new standard of care in oncology, NGS-driven diagnostics are widely observed as driving the selection of treatments to provide better outcomes to the patient population. Thus, augmenting the demand for NGS sequencers in cancer research centers. The promising outcome of clinical DNA sequencing to diagnose and treat rare genetic disorders is likely to bode well for the genome sequencing market growth. 

Consumer and genomic service providers end-user segment to witness an incremental growth of USD 1 Billion by 2026

The global genome sequencing market by academic & research institutes is expected to grow at a CAGR of 9.5% during the forecast period. The presence of several research institutes and stand-alone genomic laboratories in the US, the UK, Germany, France, and China is a major factor responsible for the growth of the segment. To develop personalized and effective new therapies that restore mobility, enhance the quality of life, and improve surgical outcomes for patients with multiple disorders, these centers perform extensive research on sequence structural levels of genomics. Hence, the increased focus on unraveling genetic components of common and complex diseases, including cancer diagnostics, neurological disorders, infectious diseases, and rare childhood disorders, influences the global DNA sequencing market. 

Genomic service providers are increasing drastically over time, especially in underdeveloped and developing countries, research institutes that are not able to afford the DNA sequencing laboratory infrastructure prefer the genomic service providers for their sample analysis. This trend has eventually increased the demand for service providers in the market. Several pharma companies are also collaborating with DNA sequencing service providers to obtain data for their product development. The reduction in the cost of the service has made companies to enter this space of genome sequencing servicing.

GEOGRAPHICAL INSIGHTS

North America and Europe are the largest genome sequencing market across the globe. They are the leading countries to increase the usage of genome based healthcare and diagnostics. The US is the largest revenue contributor to the North American market. The advanced healthcare infrastructure and the increased awareness have slowly increased genome sequencing and cell and gene therapies technology penetration. Multiple initiatives for human genome projects in the US have improved patients' flow seeking treatment for several terminal and genetic diseases. With advances in technology and the increased demand for personalized treatment, the US genomic sequencing market is poised for growth. The increased awareness among European patients drives the market of personal genome testing, especially for reproductive health. There is an increased number of consumer genomic service providers in the market.

COMPETITIVE LANDSCAPE

Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, BGI, Pacific Biosciences, Oxford Nanopore Technology are the key market players. The market is competitive and is evolving with the introduction of new technologies the market. Several companies are developing or commercializing products, expanding their manufacturing facilities, partnering with others in the market. For instance, in 2020, Illumina introduced software for whole-genome analysis to examine rare diseases. Similarly, Thermo Fischer scientific has made a strategic partnership with First genetics JCS to promote NGS in Russia. The Oxford Nanopore technology, nanopore-based sequencing, and Pacbio’s SMRT technology-based method revolutionize the industry by reducing cost and increasing throughput, attracting end-users to shift from conventional sanger methods to advanced methods in the market.

The global genome sequencing market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Product

  • Consumables
  • Sequencers & Software

Application

  • Oncology
  • Reproductive Health
  • Complex Disease Research
  • Microbial Research
  • Others

End-user

  • Academic & Research Institutes
  • Pharma & Biotech Companies
  • Consumer Genomic Service Providers
  • Government & Commercial Laboratories
  • Others

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa
    • UAE

Frequently Asked Questions

The global genome sequencing market size was valued at USD 2.9 billion in 2020 and is expected to reach USD 5 billion by 2026, growing at a CAGR of 9% during 2021-2026.
The introduction of portable gene sequencing devices and nanopore technology applications are major technological advances in the genome sequencing market.
The Global genome sequencing market is expected to grow at a CAGR of over 9% during 2021–2026.
The COVID-19 pandemic outbreak has increased pressure on clinical research and genomic research organizations across the globe due to the unavailability of resources and restriction on human mobilities.
North America and Europe are likely to hold the maximum revenue share during the forecast period.
Academic and research institutes accounted for the largest market share by end-users.
Download Free Sample

The global genome sequencing market by revenue is expected to grow at a CAGR of over 9% during the period 2021–2026.

The following factors are likely to contribute to the growth of the genome sequencing market during the forecast period:

  • Increase in Demand for Single Cell Sequencing
  • Introduction of Portable Genome Sequencing Devices
  • The emergence of Nanopore, Third Generation Genome Sequencing Platform

Base Year:                  2020

Forecast Year:           2021–2026

The study considers the genome sequencing market's present scenario and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Illumina
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Thermo Fisher Scientific
  • Oxford Nanopore Technology
  • Pacific Biosciences
  • F. Hoffmann-La Roche
  • BGI

Other Prominent Vendors

  • PerkinElmer
    • Business Overview
    • Product Offerings
  • Siemens Healthineers
  • Qiagen
  • Macrogen
  • Myriad Genetics
  • Intrexon Bioinformatics
  • Biomatters
  • Cytiva
  • 10x Genomics
  • MGI Tech
  • New England Biolabs
  • DNASTAR
  • Beckman Coulter
  • VEROGEN
  • Bio-Rad

Product

  • Consumables
  • Sequencers & Software

Application

  • Oncology
  • Reproductive Health
  • Complex Disease Research
  • Microbial Research
  • Others

End-user

  • Academic & Research Institutes
  • Pharma & Biotech Companies
  • Consumer Genomic Service Providers
  • Government & Commercial Laboratories
  • Others

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa
    • UAE

1            Research Methodology

2            Research Objectives

3            Research Process

 

4            Scope & Coverage

4.1        Market Definition

4.1.1     Inclusions

4.1.2     Exclusions

4.2        Base Year

4.3        Scope of The Study

4.4        Market Segments

4.4.1     Market Segmentation by Product

4.4.2     Market Segmentation by Application

4.4.3     Market Segmentation by End-user

4.4.4     Market Segmentation by Geography

 

5            Report Assumptions & Caveats

5.1        Key Caveats

5.2        Currency Conversion

5.3        Market Derivation

 

6            Market at a Glance

 

7            Introduction

7.1        Overview

 

8            Market Opportunities & Trends

8.1        Increase In The Demand For Single-Cell Sequencing

8.2        Introduction Of Portable Genome Sequencing Devices

8.3        Emergence Of Nanopore, Third Generation Genome Sequencing Platform

 

9            Market Growth Enablers

9.1        Rising Patient Population

9.2        Declining Cost of Genome Sequencing

9.3        Increasing Genome Sequencing Service Providers

 

10         Market Restraints

10.1      Influence Of The COVID-19 Pandemic On The Genome Sequencing Market

10.2      Low Penetration Of Genome Sequencing In Developing Countries

10.3      Ethical & Regulatory Concerns Associated With Genome Sequencing

 

11         Market Landscape

11.1      Market Overview

11.2      Market Size & Forecast

11.3      Five Forces Analysis

11.3.1   Threat of New Entrants

11.3.2   Bargaining Power of Suppliers

11.3.3   Bargaining Power of Buyers

11.3.4   Threat of Substitutes

11.3.5   Competitive Rivalry

 

12         Product

12.1      Market Snapshot & Growth Engine

12.2      Market Overview

12.3      Consumables

12.3.1   Market Overview

12.3.2   Market Size & Forecast

12.3.3   Consumables: Geography Segmentation

12.4      Sequencers & Software

12.4.1   Market Overview

12.4.2   Market Size & Forecast

12.4.3   Sequencers & Software: Geography Segmentation

 

13         Application

13.1      Market Snapshot & Growth Engine

13.2      Market Overview

13.3      Oncology

13.3.1   Market Overview

13.3.2   Market Size & Forecast

13.3.3   Oncology: Geography Segmentation

13.4      Reproductive Health

13.4.1   Market Overview

13.4.2   Market Size & Forecast

13.4.3   Reproductive Health: Geography Segmentation

13.5      Complex Disease Research

13.5.1   Market Overview

13.5.2   Market Size & Forecast

13.5.3   Complex Disease Research: Geography Segmentation

13.6      Microbial Research

13.6.1   Market Overview

13.6.2   Market Size & Forecast

13.6.3   Microbial Research: Geography Segmentation

13.7      Others

13.7.1   Market Overview

13.7.2   Market Size & Forecast

13.7.3   Others: Geography Segmentation

 

14         End-User

14.1      Market Snapshot & Growth Engine

14.2      Market Overview

14.3      Academic & Research Institutes

14.3.1   Market Overview

14.3.2   Market Size & Forecast

14.3.3   Academic & Research Institute : Geography Segmentation

14.4      Pharma & Biotechnology Companies

14.4.1   Market Overview

14.4.2   Market Size & Forecast

14.4.3   Pharma & Biotech Companies: Geography Segmentation

14.5      Consumer Genomic Service Providers

14.5.1   Market Overview

14.5.2   Market Size & Forecast

14.5.3   Consumer Genomic Service Providers: Geography Segmentation

14.6      Government and Commercial Labs

14.6.1   Market Overview

14.6.2   Market Size & Forecast

14.6.3   Government & Commercial Labs: Geography Segmentation

14.7      Others

14.7.1   Market Overview

14.7.2   Market Size & Forecast

14.7.3   Others: Geography Segmentation

 

15         Geography

15.1      Market Snapshot & Growth Engine

15.2      Geographic Overview

 

16         North America

16.1      Market Overview

16.2      Market Size & Forecast

16.3      North America: Product

16.4      North America: Application

16.5      North America: End-User

16.6      Key Countries

16.6.1   US: Market Size & Forecast

16.6.2   Canada: Market Size & Forecast

 

17         Europe

17.1      Market Overview

17.2      Market Size & Forecast

17.3      Europe: Product

17.4      Europe: Application

17.5      Europe: End-User

17.6      Key Countries

17.6.1   Germany: Market Size & Forecast

17.6.2   France: Market Size & Forecast

17.6.3   UK: Market Size & Forecast

17.6.4   Italy: Market Size & Forecast

17.6.5   Spain: Market Size & Forecast

 

18         APAC

18.1      Market Overview

18.2      Market Size & Forecast

18.3      APAC: Product

18.4      APAC: Application

18.5      APAC: End-User

18.6      Key Countries

18.6.1   China: Market Size & Forecast

18.6.2   Japan: Market Size & Forecast

18.6.3   Australia: Market Size & Forecast

18.6.4   South Korea: Market Size & Forecast

18.6.5   India: Market Size & Forecast

 

19         Latin America

19.1      Market Overview

19.2      Market Size & Forecast

19.3      Latin America: Product

19.4      Latin America: Application

19.5      Latin America: End-User

19.6      Key Countries

19.6.1   Brazil: Market Size & Forecast

19.6.2   Mexico: Market Size & Forecast

19.6.3   Argentina: Market Size & Forecast

 

20         Middle East and Africa

20.1      Market Overview

20.2      Market Size & Forecast

20.3      Middle East & Africa: Product

20.4      Middle East & Africa: Application

20.5      Middle East & Africa: End-User

20.6      Key Countries

20.6.1   Turkey: Market Size & Forecast

20.6.2   Saudi Arabia: Market Size & Forecast

20.6.3   UAE: Market Size & Forecast

20.6.4   South Africa: Market Size & Forecast

 

21         Competitive Landscape

21.1      Competition Overview

21.2      Market Share Analysis

21.2.1   Illumina

21.2.2   Thermo Fisher Scientific

21.2.3   Oxford Nanopore Technology

21.2.4   Pacific Biosciences

21.2.5   F. Hoffmann-La Roche

21.2.6   BGI

 

22         Key Company Profiles

22.1      Illumina

22.1.1   Business Overview

22.1.2   Product Offerings

22.1.3   Key Strategies

22.1.4   Key Strengths

22.1.5   Key Opportunities

22.2      Thermo Fisher Scientific

22.2.1   Business Overview

22.2.2   Product Offerings

22.2.3   Key Strategies

22.2.4   Key Strengths

22.2.5   Key Opportunities

22.3      Oxford NanoPore Technologies

22.3.1   Business Overview

22.3.2   Product Offerings

22.3.3   Key Strategy

22.3.4   Key Strengths

22.3.5   Key Opportunities

22.4      Pacific Biosciences

22.4.1   Business Overview

22.4.2   Product Offerings

22.4.3   Key Strategies

22.4.4   Key Strengths

22.4.5   Key Opportunities

22.5      F.Hoffmann-La Roche

22.5.1   Business Overview

22.5.2   Product Offerings

22.5.3   Key Strategies

22.5.4   Key Strengths

22.5.5   Key Opportunities

22.6      BGI

22.6.1   Business Overview

22.6.2   Product Offerings

22.6.3   Key Strategies

22.6.4   Key Strengths

22.6.5   Key Opportunities

 

23         Other Prominent Vendors

23.1      PerkinElmer

23.1.1   Business Overview

23.1.2   Product Offerings

23.2      Siemens Healthineers

23.2.1   Business Overview

23.2.2   Product Offerings

23.3      Qiagen

23.3.1   Business Overview

23.3.2   Product Offerings

23.4      Macrogen

23.4.1   Business Overview

23.4.2   Product Offerings

23.5      myriad Genetics

23.5.1   Business Overview

23.5.2   Product Offerings

23.6      Intrexon Bioinformatics

23.6.1   Business Overview

23.6.2   Product Offerings

23.7      Biomatter

23.7.1   Business Overview

23.7.2   Product Offerings

23.8      Cytiva

23.8.1   Business Overview

23.8.2   Product Offerings

23.9      10x Genomics

23.9.1   Business Overview

23.9.2   Product Offerings

23.10    MGI TECH

23.10.1 Business Overview

23.10.2 Product Offerings

23.11    New England Biolabs

23.11.1 Business Overview

23.11.2 Product Offerings

23.12    DNASTAR

23.12.1 Business Overview

23.12.2 Product Offerings

23.13    Beckman Coulter

23.13.1 Business Overview

23.13.2 Product Offerings

23.14    Verogen

23.14.1 Business Overview

23.14.2 Product Offerings

23.15    Bio-Rad

23.15.1 Business Overview

23.15.2 Product Offerings

 

24         Report Summary

24.1      Key Takeaways

24.2      Strategic Recommendations

 

25         Quantitative Summary

25.1      Market By Geography

25.2      Market By End-User

25.2.1   North America: End-User

25.2.2   Europe: End-User

25.2.3   APAC: End-User

25.2.4   Latin America: End-User

25.2.5   Middle East & Africa: End-User

25.3      Market By Application

25.3.1   North America: Application

25.3.2   Europe: Application

25.3.3   APAC: Application

25.3.4   Latin America: Application

25.3.5   Middle East & Africa: Application

25.4      Market By Product

25.4.1   North America: Product

25.4.2   Europe: Product

25.4.3   APAC: Product

25.4.4   Latin America: Product

25.4.5   Middle East & Africa: Product

 

26         Appendix

26.1      Abbreviations

             

 

List Of Exhibits 

Exhibit 1             Segmentation of Global Genome Sequencing Market

Exhibit 2             Market Size Calculation Approach 2020

Exhibit 3             Benefits of Next Generation Sequencing

Exhibit 4             Impact of Increase in the Demand for Single Cell Sequencing

Exhibit 5             Advantages of Sigle Cell Sequencing

Exhibit 6             Impact of Introduction of Portable Genome Sequencing Devices

Exhibit 7             Impact of Emergence of Nanopore, Third Generation Genome Sequencing Platform

Exhibit 8             Impact of Rising Patient Population

Exhibit 9             Global Rare Diseases Statistics Overview

Exhibit 10           Prevalence Rate of Selected Rare Diseases Worldwide as of 2017 (per 100,000 population)

Exhibit 11           Impact of Declining Cost of Genome Sequencing

Exhibit 12           Lower Sequencing Cost Expands Customer and Application Reach

Exhibit 13           Impact of Increasing Genome Sequencing Service Providers

Exhibit 14           Impact of the Covid-19 Pandemic on the Genome Sequencing Market

Exhibit 15           COVID-19 Cases in Key Countries

Exhibit 16           Revenue Comparison of Illumina during COVID-19 Pandemic ($million)

Exhibit 17           Impact of Low Penetration of Genome Sequencing in Developing Countries

Exhibit 18           Impact Ethical & Regulatory Concerns Associated with Genome Sequencing

Exhibit 19           Global Genome Sequencing Market 2020–2026 ($ million)

Exhibit 20           Global Genome Sequencing Market by Product

Exhibit 21           Global Genome Sequencing Market by Application

Exhibit 22           Global Genome Sequencing Market by End-user

Exhibit 23           Global Genome Sequencing Market by Geography

Exhibit 24           Five Forces Analysis 2020

Exhibit 25           Incremental Growth by Product 2020 & 2026

Exhibit 26           Global Genome Sequencing Market by Product

Exhibit 27           Global Genome Sequencing Market by Product: Incremental Growth

Exhibit 28           Global Genome Sequencing Market by Product: Absolute Growth

Exhibit 29           Global Genome Sequencing Market by Consumables: Incremental Growth versus Absolute Growth

Exhibit 30           Global Genome Sequencing Market by Consumables 2020–2026 ($ million)

Exhibit 31           Incremental Growth by Geography 2020 & 2026

Exhibit 32           Global Genome Sequencing Market by Sequencers & Softwares: Incremental Growth versus Absolute Growth

Exhibit 33           Global Genome Sequencing Market by Sequencers & Software 2020–2026 ($ million)

Exhibit 34           Incremental Growth by Geography 2020 & 2026

Exhibit 35           Incremental Growth by Application 2020 & 2026

Exhibit 36           Global Genome Sequencing Market by Application

Exhibit 37           Global Genome Sequencing Market by Application: Incremental Growth

Exhibit 38           Global Genome Sequencing Market by Application: Absolute Growth

Exhibit 39           Global Genome Sequencing Market by Oncology: Incremental Growth versus Absolute Growth

Exhibit 40           Global Genome Sequencing Market by Oncology 2020–2026 ($ million)

Exhibit 41           Incremental Growth by Geography 2020 & 2026

Exhibit 42           Global Genome Sequencing Market by Reproductive Health: Incremental Growth versus Absolute Growth

Exhibit 43           Global Genome Sequencing Market by Reproductive Health 2020–2026 ($ million)

Exhibit 44           Incremental Growth by Geography 2020 & 2026

Exhibit 45           Global Genome Sequencing Market by Complex Disease Research: Incremental Growth versus Absolute Growth

Exhibit 46           Global Genome Sequencing Market by Complex Disease Research 2020–2026 ($ million)

Exhibit 47           Incremental Growth by Geography 2020 & 2026

Exhibit 48           Global Genome Sequencing Market by Microbial Research: Incremental Growth versus Absolute Growth

Exhibit 49           Global Genome Sequencing Market by Microbial Research 2020–2026 ($ million)

Exhibit 50           Incremental Growth by Geography 2020 & 2026

Exhibit 51           Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth

Exhibit 52           Global Genome Sequencing Market by Others 2020–2026 ($ million)

Exhibit 53           Incremental Growth by Geography 2020 & 2026

Exhibit 54           Incremental Growth by End-User 2020 & 2026

Exhibit 55           Global Genome Sequencing Market by End-User

Exhibit 56           Global Genome Sequencing Market by End-User: Incremental Growth

Exhibit 57           Global Genome Sequencing Market by End-User: Absolute Growth

Exhibit 58           Global Genome Sequencing Market by Academic & Research Institutes: Incremental Growth versus Absolute Growth

Exhibit 59           Global Genome Sequencing Market by Academic & Research Institutes 2020–2026 ($ million)

Exhibit 60           Incremental Growth by Geography 2020 & 2026

Exhibit 61           Global Genome Sequencing Market by Pharma & Biotech Companies: Incremental Growth versus Absolute Growth

Exhibit 62           Global Genome Sequencing Market by Pharma & Biotechnology Companies 2020–2026 ($ million)

Exhibit 63           Incremental Growth by Geography 2020 & 2026

Exhibit 64           Global Genome Sequencing Market by Consumer Genomic Service Provider: Incremental Growth versus Absolute Growth

Exhibit 65           Global Genome Sequencing Market by Consumer Genomic Service Providers 2020–2026 ($ million)

Exhibit 66           Incremental Growth by Geography 2020 & 2026

Exhibit 67           Global Genome Sequencing Market by Government & Commercial Labs: Incremental Growth versus Absolute Growth

Exhibit 68           Global Genome Sequencing Market by Government and Commercial Labs 2020–2026 ($ million)

Exhibit 69           Incremental Growth by Geography 2020 & 2026

Exhibit 70           Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth

Exhibit 71           Global Genome Sequencing Market by Others 2020–2026 ($ million)

Exhibit 72           Incremental Growth by Geography 2020 & 2026

Exhibit 73           Incremental Growth by Geography 2020 & 2026

Exhibit 74           Global Genome Sequencing Market by Geography

Exhibit 75           Global Genome Sequencing Market by Geography: Incremental Growth

Exhibit 76           Global Genome Sequencing Market by Geography: Absolute Growth

Exhibit 77           Genome Sequencing Market in North America: Key Countries in 2020

Exhibit 78           Genome Sequencing Market in North America: Incremental Growth versus Absolute Growth

Exhibit 79           Genome Sequencing Market in North America 2020–2026 ($ million)

Exhibit 80           Incremental Growth by Product 2020 & 2026

Exhibit 81           Incremental Growth by Application 2020 & 2026

Exhibit 82           Incremental Growth by End-User 2020 & 2026

Exhibit 83           Incremental Growth in North America 2020 & 2026

Exhibit 84           Genome Sequencing Market in US 2020–2026 ($ million)

Exhibit 85           Genome Sequencing Market in Canada 2020–2026 ($ million)

Exhibit 86           Genome Sequencing Market in Europe: Key Countries in 2020

Exhibit 87           Genome Sequencing Market in Europe: Incremental Growth versus Absolute Growth

Exhibit 88           Genome Sequencing Market in Europe 2020–2026 ($ million)

Exhibit 89           Incremental Growth by Product 2020 & 2026

Exhibit 90           Incremental Growth by Application 2020 & 2026

Exhibit 91           Incremental Growth by End-User 2020 & 2026

Exhibit 92           Incremental Growth in Europe 2020 & 2026

Exhibit 93           Genome Sequencing Market in Germany 2020–2026 ($ million)

Exhibit 94           Genome Sequencing Market in France 2020–2026 ($ million)

Exhibit 95           Genome Sequencing Market in UK 2020–2026 ($ million)

Exhibit 96           Genome Sequencing Market in Italy 2020–2026 ($ million)

Exhibit 97           Genome Sequencing Market in Spain 2020–2026 ($ million)

Exhibit 98           Genome Sequencing Market in APAC: Key Countries in 2020

Exhibit 99           Genome Sequencing Market in APAC: Incremental Growth versus Absolute Growth

Exhibit 100        Genome Sequencing Market in APAC 2020–2026 ($ million)

Exhibit 101        Incremental Growth by Product 2020 & 2026

Exhibit 102        Incremental Growth by Application 2020 & 2026

Exhibit 103        Incremental Growth by End-User 2020 & 2026

Exhibit 104        Incremental Growth in APAC 2020 & 2026

Exhibit 105        Genome Sequencing Market in China 2020–2026 ($ million)

Exhibit 106        Genome Sequencing Market in Japan 2020–2026 ($ million)

Exhibit 107        Genome Sequencing Market in Australia 2020–2026 ($ million)

Exhibit 108        Genome Sequencing Market in South Korea 2020–2026 ($ million)

Exhibit 109        Genome Sequencing Market in India 2020–2026 ($ million)

Exhibit 110        Genome Sequencing Market in Latin America: Key Countries in 2020

Exhibit 111        Global Genome Sequencing Market in Latin America: Incremental Growth versus Absolute Growth

Exhibit 112        Genome Sequencing Market in Latin America 2020–2026 ($ million)

Exhibit 113        Incremental Growth by Product 2020 & 2026

Exhibit 114        Incremental Growth by Application 2020 & 2026

Exhibit 115        Incremental Growth by End-User 2020 & 2026

Exhibit 116        Incremental Growth in Latin America 2020 & 2026

Exhibit 117        Genome Sequencing Market in Brazil 2020–2026 ($ million)

Exhibit 118        Genome Sequencing Market in Mexico 2020–2026 ($ million)

Exhibit 119        Genome Sequencing Market in Argentina 2020–2026 ($ million)

Exhibit 120        Genome Sequencing Market in Middle East & Africa: Key Countries in 2020

Exhibit 121        Genome Sequencing Market in Middle East & Africa: Incremental Growth versus Absolute Growth

Exhibit 122        Genome Sequencing Market in Middle East & Africa 2020–2026 ($ million)

Exhibit 123        Incremental Growth by Product 2020 & 2026

Exhibit 124        Incremental Growth by Application 2020 & 2026

Exhibit 125        Incremental Growth by End-User 2020 & 2026

Exhibit 126        Incremental Growth in Middle East & Africa 2020 & 2026

Exhibit 127        Genome Sequencing Market in Turkey 2020–2026 ($ million)

Exhibit 128        Genome Sequencing Market in Saudi Arabia 2020–2026 ($ million)

Exhibit 129        Genome Sequencing Market in UAE 2020–2026 ($ million)

Exhibit 130        Genome Sequencing Market in South Africa 2020–2026 ($ million)

Exhibit 131        Vendor’s Market Shares in the Global Genome Sequencing Market-2020

Exhibit 132        Illumina Revenue 2017−2019 ($ millions)

Exhibit 133        Illumina Research & Development Expenditure 2017−2019 ($ millions)

Exhibit 134        Illumina Consumables & Sequencers Revenue 2017−2019 ($ millions)

Exhibit 135        Thermo Fisher Scientific Revenue 2017−2019 ($ millions)

Exhibit 136        Thermo Fisher Scientific Research & Development Expenditure 2017−2019 ($ millions)

Exhibit 137        Thermo Fisher Scientific: Revenue by Geography (%)

             

             

             

List Of Tables   

Table 1               Key Caveats

Table 2               Currency Conversion 2013−2020

Table 3               Comparison of Portable NGS Approaches to Existing Technologies

Table 4               Lower Sequencing Cost Broadens Customer and Application Reach

Table 5               Key Genome Sequencing Service Providers

Table 6               Various Generations of Sequencing Technologies

Table 7               Major Genome Sequencing Research Institutes

Table 8               Global Genome Sequencing Market: Vendors Ranking

Table 9               Illumina: Major Product Offerings

Table 10             Thermo Fisher Scientific: Major Product Offerings

Table 11             Oxford Nanopore Technologies: Major Product Offerings

Table 12             Pacific Biosciences: Major Product Offerings

Table 13             F. Hoffmann-La Roche: Major Product Offerings

Table 14             BGI: Major Product Offerings

Table 15             PerkinElmer: Major Product Offerings

Table 16             Siemens Healthineers: Major Product Offerings

Table 17             Qiagen: Major Product Offerings

Table 18             Macrogen: Major Product Offerings

Table 19             Myriad Genetics: Major Product Offerings

Table 20             Intrexon Bioinformatics: Major Product Offerings

Table 21             BioMatter: Major Product Offerings

Table 22             Cytiva: Major Product Offerings

Table 23             10x Genomics: Major Product Offerings

Table 24             MGI Tech: Major Product Offerings

Table 25             New England Biolabs: Major Product Offerings

Table 26             DNASTAR: Major Product Offerings

Table 27             Beckman Coulter: Major Product Offerings

Table 28             VEROGEN: Major Product Offerings

Table 29             Bio-Rad: Major Product Offerings

Table 30             Global Genome Sequencing Market by Geography 2020−2026 ($ million)

Table 31             Global Genome Sequencing Market by Geography 2020−2026 (%)

Table 32             Global Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 33             Global Genome Sequencing Market by End-User 2020−2026 (%)

Table 34             North America Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 35             North America Genome Sequencing Market by End-User 2020−2026 (%)

Table 36             Europe Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 37             Europe Genome Sequencing Market by End-User 2020−2026 (%)

Table 38             APAC Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 39             APAC Genome Sequencing Market by End-User 2020−2026 (%)

Table 40             Latin America Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 41             Latin America Genome Sequencing Market by End-User 2020−2026 (%)

Table 42             Middle East & Africa Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 43             Middle East & Africa Genome Sequencing Market by End-User 2020−2026 (%)

Table 44             Global Genome Sequencing Market by Application 2020−2026 ($ million)

Table 45             Global Genome Sequencing Market by Application 2020−2026 (%)

Table 46             North America Genome Sequencing Market by Application 2020−2026 ($ million)

Table 47             North America Genome Sequencing Market by Application 2020−2026 (%)

Table 48             Europe Genome Sequencing Market by Application 2020−2026 ($ million)

Table 49             Europe Genome Sequencing Market by Application 2020−2026 (%)

Table 50             APAC Genome Sequencing Market by Application 2020−2026 ($ million)

Table 51             APAC Genome Sequencing Market by Application 2020−2026 (%)

Table 52             Latin America Genome Sequencing Market by Application 2020−2026 ($ million)

Table 53             Latin America Genome Sequencing Market by Application 2020−2026 (%)

Table 54             Middle East & Africa Genome Sequencing Market by Application 2020−2026 ($ million)

Table 55             Middle East & Africa Genome Sequencing Market by Application 2020−2026 (%)

Table 56             Global Genome Sequencing Market by Product 2020−2026 ($ million)

Table 57             Global Genome Sequencing Market by Product 2020−2026 (%)

Table 58             North America Genome Sequencing Market by Product 2020−2026 ($ million)

Table 59             North America Genome Sequencing Market by Product 2020−2026 (%)

Table 60             Europe Genome Sequencing Market by Product 2020−2026 ($ million)

Table 61             Europe Genome Sequencing Market by Product 2020−2026 (%)

Table 62             APAC Genome Sequencing Market by Product 2020−2026 ($ million)

Table 63             APAC Genome Sequencing Market by Product 2020−2026 (%)

Table 64             Latin America Genome Sequencing Market by Product 2020−2026 ($ million)

Table 65             Latin America Genome Sequencing Market by Product 2020−2026 (%)

Table 66             Middle East & Africa Genome Sequencing Market by Product 2020−2026 ($ million)

Table 67             Middle East &Africa Genome Sequencing Market by Product 2020−2026 (%)

Select a license type that suits your business needs

Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date